An AIDS warning was added to US product information in December 1983, however the earliest product warning in the UK which the Inquiry was able to identify was in March 1984. Read more about An AIDS warning was added to US product information in December 1983, however the earliest product warning in the UK which the Inquiry was able to identify was in March 1984.
Professor Arthur Bloom maintained to the annual general meeting of haemophilia centre directors there was no proof that commercial concentrates were the cause of AIDS. Read more about Professor Arthur Bloom maintained to the annual general meeting of haemophilia centre directors there was no proof that commercial concentrates were the cause of AIDS.
Cutter and the FDA noted that: "Isolated cases of Acquired Immune Deficiency Syndrome (AIDS) have been reported in hemophilics [sic] who have received blood and/or coagulation factor concentrates, including Factor VIII concentrates." Read more about Cutter and the FDA noted that: "Isolated cases of Acquired Immune Deficiency Syndrome (AIDS) have been reported in hemophilics [sic] who have received blood and/or coagulation factor concentrates, including Factor VIII concentrates."
Cutter and the FDA discussed adding an AIDS warning to US product information, leading to the addition of such a warning in December. Read more about Cutter and the FDA discussed adding an AIDS warning to US product information, leading to the addition of such a warning in December.
During the licensing process, the licensing authority required references to heat treatment to be that it was intended to "reduce the risk of transmission of infectious agents" rather than making claims about it reducing the risks of HIV or non-A non-B Hepatitis by name. Read more about During the licensing process, the licensing authority required references to heat treatment to be that it was intended to "reduce the risk of transmission of infectious agents" rather than making claims about it reducing the risks of HIV or non-A non-B Hepatitis by name.
Alpha warned on the package insert for Antihaemophilic Factor (Human) dried Profilate Heat-Treated "The causal factors of Acquired Immune Deficiency Syndrome...have no been fully defined. However, HTLV-III/LAV virus has been implicated as a possible agent of the disease." Read more about Alpha warned on the package insert for Antihaemophilic Factor (Human) dried Profilate Heat-Treated "The causal factors of Acquired Immune Deficiency Syndrome...have no been fully defined. However, HTLV-III/LAV virus has been implicated as a possible agent of the disease."
A press release stated Alpha had contacted its "several hundred plasma suppliers" and they "must 'exclude donors' who may be part of three potentially high-risk groups: persons who have been in Haiti: drug abusers and male homosexuals. There is a 'higher incidence of AIDS' in these groups than in the community at large, the company says." Read more about A press release stated Alpha had contacted its "several hundred plasma suppliers" and they "must 'exclude donors' who may be part of three potentially high-risk groups: persons who have been in Haiti: drug abusers and male homosexuals. There is a 'higher incidence of AIDS' in these groups than in the community at large, the company says."
Ian Marshall wrote to Professor Bloom stating that the three high risk groups were excluded from 27 December 1982 but in the press release it gave the date of 20 December 1982. Read more about Ian Marshall wrote to Professor Bloom stating that the three high risk groups were excluded from 27 December 1982 but in the press release it gave the date of 20 December 1982.
David Gury at Alpha sent out a series of urgent communications on AIDS on their new donor selection policies which were due to be be given to donors, deferred donors and donor centre personnel. Read more about David Gury at Alpha sent out a series of urgent communications on AIDS on their new donor selection policies which were due to be be given to donors, deferred donors and donor centre personnel.
The warning label on Armour's Factorate package continued to state that the risk of transmitting viral hepatitis to patients was still present, and personnel administering this should exercise caution. Read more about The warning label on Armour's Factorate package continued to state that the risk of transmitting viral hepatitis to patients was still present, and personnel administering this should exercise caution.